Egyptian Journal of Otolaryngology (EJOT) is a premier open access journal dedicated to advancing the field of otorhinolaryngology. Published by Springer, the journal has been an essential resource for researchers and practitioners since its transition to open access in 2012. With an ISSN of 1012-5574 and E-ISSN 2090-8539, EJOT aims to facilitate the dissemination of high-quality research, covering a broad spectrum of topics within otolaryngology. The journal's significance is underscored by its current ranking in the Q3 category of the Scopus Otorhinolaryngology category, and it is positioned in the 23rd percentile of its field, reflecting its commitment to scholarly excellence. Researchers, professionals, and students alike will find valuable insights and innovative studies in the journal's articles, contributing to ongoing education and the advancement of best practices in ear, nose, and throat medicine. The journal is based in Germany with its operations centered at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, UNITED STATES, ensuring a global reach in the academic community.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

Journal of Laryngology and Otology, published by Cambridge University Press, is a prestigious peer-reviewed journal dedicated to the fields of laryngology and otology. With its rich history dating back to 1891, the journal provides a platform for cutting-edge research, review articles, and clinical studies that advance the understanding and treatment of disorders related to the ear, nose, and throat. As evidenced by its ranking in the Q2 category for both Medicine (miscellaneous) and Otorhinolaryngology, the journal is recognized for its significant contributions to medical literature, holding its place at Rank #45 among 123 in the Scopus database for this specialty. Although it does not offer open access, it is widely accessible to professionals and academics in the field, and remains an invaluable resource for those seeking to stay updated with the latest advancements in laryngology and otology. The ISSN for the journal is 0022-2151 and the E-ISSN is 1748-5460, ensuring its broad reach and appeal within the global scientific community.

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

AURIS NASUS LARYNX, published by Elsevier Science Ltd, is a leading peer-reviewed journal specializing in the fields of otorhinolaryngology, surgery, and general medicine. Since its inception in 1974, this esteemed journal has been committed to disseminating high-quality research and innovative findings pertinent to the diagnosis, treatment, and management of ear, nose, and throat diseases. With an impressive 2023 impact factor reflected in its Q2 quartile rankings in both Medicine (miscellaneous) and Otorhinolaryngology, as well as its strong position in Surgery, AURIS NASUS LARYNX is regarded highly among researchers and practitioners. The journal is accessible through a subscription model, ensuring that essential knowledge remains within reach for both clinical and academic pursuits. The continuous evolution of its content promises to stay at the forefront of medical advancements, making it an invaluable resource for scholars, clinicians, and students striving for excellence in the medical field.

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.

Head & Face Medicine, published by BMC, serves as a vital open-access platform for advancing research and clinical practices in the fields of Dentistry, Otorhinolaryngology, and Neurology. Since its inception in 2005, this journal has nurtured contributions that span a diverse range of topics, making significant strides in understanding complex head and facial conditions. With an impressive categorization in the 2023 Journal Rankings, where it is recognized in Q1 for both Dentistry and Otorhinolaryngology, as well as Q2 for Neurology, it holds a prestigious position in the academic community, fostering innovative ideas and collaborations. The journal's commitment to free access ensures widespread availability of groundbreaking research, promoting knowledge dissemination among researchers, healthcare professionals, and students alike. Located in the United Kingdom and continuously prioritizing rigorous peer review, Head & Face Medicine is essential for anyone seeking to stay at the forefront of medical advancements concerning head and facial health.

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

The ANNALS OF SURGICAL ONCOLOGY, published by SPRINGER, stands as a leading journal dedicated to advancing the field of surgical oncology. With an ISSN of 1068-9265 and an E-ISSN of 1534-4681, this esteemed publication features high-quality research from 1994 to 2024, contributing significantly to the scientific dialogue surrounding surgical techniques, treatment innovations, and patient outcomes within the oncology community. The journal has earned a prestigious Q1 ranking in Surgery and a Q2 in Oncology for 2023, reflecting its pivotal role in influencing clinical practices and research in these fields. According to Scopus metrics, it ranks #51 out of 551 in Medicine Surgery and #133 out of 404 in Medicine Oncology, underscoring its academic rigor and impact. Despite being a subscription-based journal, the depth of knowledge disseminated through its pages is invaluable for researchers, professionals, and students aiming to stay at the forefront of surgical oncology advancements.